Which ETFs hold Chugai Pharmaceutical Co Ltd (4519)?
Japanese drugmaker majority owned by Roche, known for cancer and immunology medicines.
26 Australian ETFs hold Chugai Pharmaceutical Co Ltd, a Health Care company from Japan. HLTH has the biggest weighting at 1.94%. Across these funds, Australian ETF investors own about $45m of Chugai Pharmaceutical Co Ltd.
The ETFs with the most Chugai Pharmaceutical Co Ltd
All 26 ETFs that hold Chugai Pharmaceutical Co Ltd, ranked by weight
Best-endeavours estimate. Built from each issuer's published holdings, which may be weeks or months old, may cover only part of a fund (some publish only their top 10) and are matched by company name. Figures may be incomplete or inaccurate. Check the issuer's website and PDS before relying on them. General information only.
Weights from each issuer's published holdings (September to November 2026). Some funds list only their largest holdings. General information only, not a recommendation to buy or sell Chugai Pharmaceutical Co Ltd.
Common questions
Which ETF has the most Chugai Pharmaceutical Co Ltd?
HLTH (VanEck Global Healthcare Leaders ETF) has the highest weighting, with 1.94% of the fund in Chugai Pharmaceutical Co Ltd.
What is the cheapest ETF that holds Chugai Pharmaceutical Co Ltd?
Of the ETFs where Chugai Pharmaceutical Co Ltd is at least 1% of the fund, HLTH has the lowest fee at 0.45% a year, with 1.94% in Chugai Pharmaceutical Co Ltd.
How much Chugai Pharmaceutical Co Ltd do I own with $10,000 in QUAL?
About $9. QUAL is the largest ETF that holds Chugai Pharmaceutical Co Ltd, and Chugai Pharmaceutical Co Ltd makes up 0.09% of it.
How many Australian ETFs hold Chugai Pharmaceutical Co Ltd?
26 ETFs listed on the ASX or TMX Australia hold Chugai Pharmaceutical Co Ltd, based on issuers' published holdings.